Two Sigma Investments’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-50,095
| Closed | -$4.66M | – | 4787 |
|
|
2021
Q4 | $4.66M | Buy |
50,095
+45,819
| +1,072% | +$3.02M | 0.01% | 1233 |
|
|
2021
Q3 | $255K | Buy |
+4,276
| New | +$253K | ﹤0.01% | 3788 |
|
|
2021
Q2 | – | Sell |
-234,251
| Closed | -$16.3M | – | 4770 |
|
|
2021
Q1 | $16.3M | Buy |
+234,251
| New | +$18M | 0.04% | 508 |
|
|
2020
Q4 | – | Sell |
-188,900
| Closed | -$14.1M | – | 3910 |
|
|
2020
Q3 | $14.1M | Buy |
188,900
+151,224
| +401% | +$10.1M | 0.05% | 399 |
|
|
2020
Q2 | $2.37M | Buy |
+37,676
| New | +$2.07M | 0.01% | 1013 |
|
|
2018
Q3 | – | Sell |
-29,916
| Closed | -$1.3M | – | 3742 |
|
|
2018
Q2 | $1.3M | Sell |
29,916
-9,126
| -23% | -$392K | ﹤0.01% | 1947 |
|
|
2018
Q1 | $1.54M | Buy |
+39,042
| New | +$1.52M | 0.01% | 1712 |
|
|
2017
Q2 | – | Sell |
-31,283
| Closed | -$457K | – | 3396 |
|
|
2017
Q1 | $457K | Buy |
31,283
+30,242
| +2,905% | +$448K | ﹤0.01% | 2389 |
|
|
2016
Q4 | $15K | Buy |
+1,041
| New | +$16.1K | ﹤0.01% | 3021 |
|
|
2014
Q2 | – | Sell |
-4,302
| Closed | -$271K | – | 2414 |
|
|
2014
Q1 | $271K | Buy |
4,302
+3,188
| +286% | +$212K | ﹤0.01% | 1720 |
|
|
2013
Q4 | $65K | Sell |
1,114
-1,319
| -54% | -$68.9K | ﹤0.01% | 2112 |
|
|
2013
Q3 | $128K | Buy |
+2,433
| New | +$163K | ﹤0.01% | 1722 |
|
Two Sigma Investments's ARNA Position: Q1 2022 in Review
Two Sigma Investments sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 50,095 shares — an estimated $4.66M sold.
Two Sigma Investments first reported a position in ARNA in Q3 2013 and held it in 12 quarters. The position peaked at $16.3M in Q1 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Two Sigma Investments reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Two Sigma Investments sold 50,095 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $4.66M.
- Two Sigma Investments first reported a position in Arena Pharmaceuticals Inc in Q3 2013 and held it in 12 quarters.
- Two Sigma Investments's Arena Pharmaceuticals Inc position peaked at $16.3M in Q1 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.